EXO1 and nasopharyngeal carcinoma: To explore whether LINC00173/RAB1B regulates the PA2G4 and SDF4 secretion through the exocytic pathway, we first treated NPC cells with Exo‐1, a chemical inhibitor of the exocytic pathway [22].